Search Results

Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab.

• Authors : Kizilocak, Hande (AUTHOR); Marquez‐Casas, Elizabeth (AUTHOR); Malvar, Jemily (AUTHOR)

Subjects: BISPECIFIC antibodies; EMICIZUMAB; PROTHROMBIN

• Source: Haemophilia. Jan2023, Vol. 29 Issue 1, p100-105. 6p. 1 Diagram, 2 Charts, 1 Graph.

Record details

Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study.

• Authors : Mingot‐Castellano, María E.^1,2 (AUTHOR) ; García‐Candel, Faustino³ (AUTHOR); Benítez‐Hidalgo, Olga⁴ (AUTHOR)

Subjects: *HEMOPHILIA; *PROTHROMBIN; *HEMORRHAGE

• Source: European Journal of Haematology. Dec2022, Vol. 109 Issue 6, p686-695. 10p.

Record details

Registry of Hemophilia and other bleeding disorders in Syria.

• Authors : Ali, T.¹; Schved, J. F.²

Subjects: *HEMOPHILIA; *PROTHROMBIN; *BLOOD coagulation factorsSYRIA

• Source: Haemophilia. Nov2012, Vol. 18 Issue 6, p851-854. 4p. 2 Charts, 1 Graph.

Record details

Recent Studies from Istanbul University Add New Data to Hemophilia (Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors).

Subjects: HEMOPHILIA; PROTHROMBIN; BLOOD coagulation factorsISTANBUL Universitesi

• Source: Clinical Trials Week; 7/22/2024, p297-297, 1p

Record details

Saitama Children's Medical Center Reports Findings in Hemophilia (Regular prophylaxis with activated prothrombin complex concentrates in pediatric hemophilia).

Subjects: PROTHROMBIN; HEMOPHILIA; BLOOD coagulation factors

• Source: Pediatrics Week; 7/13/2024, p463-463, 1p

Record details

The clinical phenotype modulation of haemophilia by prothrombotic gene mutations.

• Authors : Araújo, F.; Fraga, M.; Henriques, I.

Subjects: *HEMOPHILIA; *PROTHROMBIN; *GENETIC mutation

• Source: Haemophilia. Mar2003, Vol. 9 Issue 2, p235-236. 2p.

Record details

Recombinant human prothrombin (MEDI8111) prevents bleeding in haemophilia A and B mice.

• Authors : Hansson, K. M.¹; Lindblom, A.¹; Elg, M.¹

Subjects: *PROTHROMBIN; *HEMORRHAGE prevention; *BLOOD coagulation factor VIII

• Source: Haemophilia. May2016, Vol. 22 Issue 3, p453-461. 9p.

Record details

The effect of the Dietary Approaches to Stop Hypertension (DASH) diet on body composition, complete blood count, prothrombin time, inflammation and liver function in haemophilic adolescents.

• Authors : Mahdavi, Atena; Mohammadi, Hamed; Bagherniya, Mohammad

Subjects: LIVER physiology; BODY composition; PROTHROMBIN time

• Source: British Journal of Nutrition; 11/14/2022, Vol. 128 Issue 9, p1771-1779, 9p

Record details

A 9-year-old patient with severe haemophilia A complicated by factor VIII inhibitor treated with emicizumab -- case report and literature review.

• Authors : Małgorzata Tomasik, Justyna; Szuba, Joanna; Chrostowski, Kacper

Subjects: HEMOPHILIA; PROTHROMBIN; IMMUNOLOGICAL tolerance

• Source: Journal of Pre-Clinical & Clinical Research; 2024, Vol. 18 Issue 2, p128-134, 7p

Record details

Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis.

• Authors : Rossignon, P.; Grandjean, F.; Claessens, A.

Subjects: HEMOPHILIA; PARTIAL thromboplastin time; PLASMA cells

• Source: Case Reports in Hematology; 12/13/2023, p1-6, 6p

Record details